January 28, 2025 - 06:11

Hebrew SeniorLife has announced a significant achievement for its Deanna and Sidney Wolk Center for Memory Health. The center has been awarded the prestigious level 2 Age-Friendly Health System designation by the Institute of Healthcare Improvement (IHI). This recognition highlights the center’s commitment to delivering high-quality care tailored to the unique needs of older adults.
The Age-Friendly Health System initiative focuses on providing care that is aligned with the principles of age-friendliness, ensuring that health services are respectful and responsive to the individual preferences, needs, and values of senior patients. Achieving level 2 status signifies that the Wolk Center has demonstrated a commitment to care excellence, implementing practices that enhance the well-being of its patients.
This recognition underscores Hebrew SeniorLife's dedication to improving the health and quality of life for seniors in the community. As New England's largest nonprofit provider of senior health care, the organization continues to set standards in age-friendly care, reinforcing its role as a leader in the field.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...